Effect of chronic right ventricular apical pacing on left ventricular function

James H. O'Keefe, Hussam Abuissa, Philip G. Jones, Randall C. Thompson, Timothy M. Bateman, A. Iain McGhie, Brian M. Ramza, David M. Steinhaus

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

The determinants of change in left ventricular (LV) ejection fraction (EF) over time in patients with impaired LV function at baseline have not been clearly established. Using a nuclear database to assess changes in LV function over time, we included patients with a baseline LVEF of 25% to 40% on a gated single-photon emission computed tomographic study at rest and only if second-gated photon emission computed tomography performed approximately 18 months after the initial study showed an improvement in LVEF at rest of ≥10 points or a decrease in LVEF at rest of ≥7 points. In all, 148 patients qualified for the EF increase group and 59 patients for the EF decrease group. LVEF on average increased from 33 ± 4% to 51 ± 8% in the EF increase group and decreased from 35 ± 4% to 25 ± 5% in the EF decrease group. The strongest multivariable predictor of improvement of LVEF was β-blocker therapy (odds ratio 3.9, p = 0.002). The strongest independent predictor of LVEF decrease was the presence of a permanent right ventricular apical pacemaker (odds ratio 6.6, p = 0.002). Thus, this study identified β-blocker therapy as the major independent predictor for improvement in LVEF of ≥10 points, whereas a permanent pacemaker (right ventricular apical pacing) was the strongest predictor of a LVEF decrease of ≥7 points.

Original languageEnglish
Pages (from-to)771-773
Number of pages3
JournalAmerican Journal of Cardiology
Volume95
Issue number6
DOIs
StatePublished - Mar 15 2005
Externally publishedYes

Fingerprint

Left Ventricular Function
Photons
Odds Ratio
Emission-Computed Tomography
Stroke Volume
Databases
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

O'Keefe, J. H., Abuissa, H., Jones, P. G., Thompson, R. C., Bateman, T. M., McGhie, A. I., ... Steinhaus, D. M. (2005). Effect of chronic right ventricular apical pacing on left ventricular function. American Journal of Cardiology, 95(6), 771-773. https://doi.org/10.1016/j.amjcard.2004.11.034

Effect of chronic right ventricular apical pacing on left ventricular function. / O'Keefe, James H.; Abuissa, Hussam; Jones, Philip G.; Thompson, Randall C.; Bateman, Timothy M.; McGhie, A. Iain; Ramza, Brian M.; Steinhaus, David M.

In: American Journal of Cardiology, Vol. 95, No. 6, 15.03.2005, p. 771-773.

Research output: Contribution to journalArticle

O'Keefe, JH, Abuissa, H, Jones, PG, Thompson, RC, Bateman, TM, McGhie, AI, Ramza, BM & Steinhaus, DM 2005, 'Effect of chronic right ventricular apical pacing on left ventricular function', American Journal of Cardiology, vol. 95, no. 6, pp. 771-773. https://doi.org/10.1016/j.amjcard.2004.11.034
O'Keefe, James H. ; Abuissa, Hussam ; Jones, Philip G. ; Thompson, Randall C. ; Bateman, Timothy M. ; McGhie, A. Iain ; Ramza, Brian M. ; Steinhaus, David M. / Effect of chronic right ventricular apical pacing on left ventricular function. In: American Journal of Cardiology. 2005 ; Vol. 95, No. 6. pp. 771-773.
@article{dc7df9f0c52e47d3ab03d8db92ece5b6,
title = "Effect of chronic right ventricular apical pacing on left ventricular function",
abstract = "The determinants of change in left ventricular (LV) ejection fraction (EF) over time in patients with impaired LV function at baseline have not been clearly established. Using a nuclear database to assess changes in LV function over time, we included patients with a baseline LVEF of 25{\%} to 40{\%} on a gated single-photon emission computed tomographic study at rest and only if second-gated photon emission computed tomography performed approximately 18 months after the initial study showed an improvement in LVEF at rest of ≥10 points or a decrease in LVEF at rest of ≥7 points. In all, 148 patients qualified for the EF increase group and 59 patients for the EF decrease group. LVEF on average increased from 33 ± 4{\%} to 51 ± 8{\%} in the EF increase group and decreased from 35 ± 4{\%} to 25 ± 5{\%} in the EF decrease group. The strongest multivariable predictor of improvement of LVEF was β-blocker therapy (odds ratio 3.9, p = 0.002). The strongest independent predictor of LVEF decrease was the presence of a permanent right ventricular apical pacemaker (odds ratio 6.6, p = 0.002). Thus, this study identified β-blocker therapy as the major independent predictor for improvement in LVEF of ≥10 points, whereas a permanent pacemaker (right ventricular apical pacing) was the strongest predictor of a LVEF decrease of ≥7 points.",
author = "O'Keefe, {James H.} and Hussam Abuissa and Jones, {Philip G.} and Thompson, {Randall C.} and Bateman, {Timothy M.} and McGhie, {A. Iain} and Ramza, {Brian M.} and Steinhaus, {David M.}",
year = "2005",
month = "3",
day = "15",
doi = "10.1016/j.amjcard.2004.11.034",
language = "English",
volume = "95",
pages = "771--773",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Effect of chronic right ventricular apical pacing on left ventricular function

AU - O'Keefe, James H.

AU - Abuissa, Hussam

AU - Jones, Philip G.

AU - Thompson, Randall C.

AU - Bateman, Timothy M.

AU - McGhie, A. Iain

AU - Ramza, Brian M.

AU - Steinhaus, David M.

PY - 2005/3/15

Y1 - 2005/3/15

N2 - The determinants of change in left ventricular (LV) ejection fraction (EF) over time in patients with impaired LV function at baseline have not been clearly established. Using a nuclear database to assess changes in LV function over time, we included patients with a baseline LVEF of 25% to 40% on a gated single-photon emission computed tomographic study at rest and only if second-gated photon emission computed tomography performed approximately 18 months after the initial study showed an improvement in LVEF at rest of ≥10 points or a decrease in LVEF at rest of ≥7 points. In all, 148 patients qualified for the EF increase group and 59 patients for the EF decrease group. LVEF on average increased from 33 ± 4% to 51 ± 8% in the EF increase group and decreased from 35 ± 4% to 25 ± 5% in the EF decrease group. The strongest multivariable predictor of improvement of LVEF was β-blocker therapy (odds ratio 3.9, p = 0.002). The strongest independent predictor of LVEF decrease was the presence of a permanent right ventricular apical pacemaker (odds ratio 6.6, p = 0.002). Thus, this study identified β-blocker therapy as the major independent predictor for improvement in LVEF of ≥10 points, whereas a permanent pacemaker (right ventricular apical pacing) was the strongest predictor of a LVEF decrease of ≥7 points.

AB - The determinants of change in left ventricular (LV) ejection fraction (EF) over time in patients with impaired LV function at baseline have not been clearly established. Using a nuclear database to assess changes in LV function over time, we included patients with a baseline LVEF of 25% to 40% on a gated single-photon emission computed tomographic study at rest and only if second-gated photon emission computed tomography performed approximately 18 months after the initial study showed an improvement in LVEF at rest of ≥10 points or a decrease in LVEF at rest of ≥7 points. In all, 148 patients qualified for the EF increase group and 59 patients for the EF decrease group. LVEF on average increased from 33 ± 4% to 51 ± 8% in the EF increase group and decreased from 35 ± 4% to 25 ± 5% in the EF decrease group. The strongest multivariable predictor of improvement of LVEF was β-blocker therapy (odds ratio 3.9, p = 0.002). The strongest independent predictor of LVEF decrease was the presence of a permanent right ventricular apical pacemaker (odds ratio 6.6, p = 0.002). Thus, this study identified β-blocker therapy as the major independent predictor for improvement in LVEF of ≥10 points, whereas a permanent pacemaker (right ventricular apical pacing) was the strongest predictor of a LVEF decrease of ≥7 points.

UR - http://www.scopus.com/inward/record.url?scp=14744299952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14744299952&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2004.11.034

DO - 10.1016/j.amjcard.2004.11.034

M3 - Article

C2 - 15757609

AN - SCOPUS:14744299952

VL - 95

SP - 771

EP - 773

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 6

ER -